Pulmonary Hypertension as a Risk Factor for Death in Patients with Sickle Cell Disease
The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The prevalence of pulmonary hypertension in adults with sickle cell disease, the mechanism of its development, and its prospective prognostic significance are unknown. METHODS: We performed Doppler echocardiographic assessments of pulmonary-artery systolic pressure in 195 consecutive patients (82 men and 113 women; mean [+/-SD] age, 36+/-12 years). Pulmonary hypertension was prospectively defined as a tricuspid regurgitant jet velocity of at least 2.5 m per second. Patients were followed for a mean of 18 months, and data were censored at the time of death or loss to follow-up. RESULTS: Doppler-defined pulmonary hypertension occurred in 32 percent of patients. Multiple logistic-regression analysis, with the use of the dichotomous variable of a tricuspid regurgitant jet velocity of less than 2.5 m per second or 2.5 m per second or more, identified a self-reported history of cardiovascular or renal complications, increased systolic blood pressure, high lactate dehydrogenase levels (a marker of hemolysis), high levels of alkaline phosphatase, and low transferrin levels as significant independent correlates of pulmonary hypertension. The fetal hemoglobin level, white-cell count, and platelet count and the use of hydroxyurea therapy were unrelated to pulmonary hypertension. A tricuspid regurgitant jet velocity of at least 2.5 m per second, as compared with a velocity of less than 2.5 m per second, was strongly associated with an increased risk of death (rate ratio, 10.1; 95 percent confidence interval, 2.2 to 47.0; P<0.001) and remained so after adjustment for other possible risk factors in a proportional-hazards regression model. CONCLUSIONS: Pulmonary hypertension, diagnosed by Doppler echocardiography, is common in adults with sickle cell disease. It appears to be a complication of chronic hemolysis, is resistant to hydroxyurea therapy, and confers a high risk of death. Therapeutic trials targeting this population of patients are indicated.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Patients with higher rates of hemolysis have lower steady-state Hb levels and are more likely to develop vascular injury and organ dysfunction as they age, manifesting as pulmonary hypertension, diastolic left heart disease, and renal dysfunction (proteinuria, albuminuria, and chronic kidney dysfunction) (62, 64, 65, 70, 79).”
From Pathophysiology of Sickle Cell Disease (2019) · cites this paper as [64]
Citations
Cites
Recommendations for Quantitation of the Left Ventricle by Two-Dimensional Echocardiography
Schiller, N. B., Shah, P. M., Crawford, M., DeMaria, A., Devereux, R., Feigenbaum, H., Gutgesell, H., Reichek, N., Sahn, D., Schnittger, I., et al. (1989) · Journal of the American Society of Echocardiography · doi:10.1016/s0894-7317(89)80014-8 · Cited by 8,121
Mortality in sickle cell disease. Life expectancy and risk factors for early death
Platt, O. S., Brambilla, D. J., Rosse, W. F., Milner, P. F., Castro, O., Steinberg, M. H., & Klug, P. P. (1994) · New England Journal of Medicine · doi:10.1056/nejm199406093302303 · Cited by 3,320
Self-citationQuiñones, M. A., Otto, C. M., Stoddard, M., Waggoner, A., & Zoghbi, W. A. (2002) · Journal of the American Society of Echocardiography · doi:10.1067/mje.2002.120202 · Cited by 2,130
Adams, R. J., McKie, V. C., Hsu, L., Files, B., Vichinsky, E., Pegelow, C., Abboud, M., Gallagher, D., Kutlar, A., Nichols, F. T., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807023390102 · Cited by 1,866
De Caterina, R., Libby, P., Peng, H. B., Thannickal, V. J., Rajavashisth, T. B., Gimbrone, M. A., Shin, W. S., & Liao, J. K. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118074 · Cited by 1,782
Primary Pulmonary Hypertension
Rubin, L. J. (1997) · New England Journal of Medicine · doi:10.1056/nejm199701093360207 · Cited by 1,726
Cerebrovascular accidents in sickle cell disease: rates and risk factors.
(1998) · PubMed · doi:10.1182/blood.v91.1.288 · Cited by 1,694
Dams, R. O. J. A., Ie, V. I. C. M. C. K., Su, L. E. H., Iles, B. E. F., Ichinsky, E. L. V., Egelow, C. H. P., Bboud, M. I. A., Allagher, D. I. G., Utlar, K., Ichols, F. E. T. N., et al. (2015) · Cited by 1,338
Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease
Reiter, C. D., Wang, X., Tanus-Santos, J. E., Hogg, N., Cannon, R. O., Schechter, A. N., & Gladwin, M. T. (2002) · Nature Medicine · doi:10.1038/nm1202-799 · Cited by 1,330
Self-citationCell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease
Reiter, C. D., Wang, X., Tanus-Santos, J. E., et al. (2002) · Nature Medicine · doi:10.1038/nm799 · Cited by 1,097
Cited by
Items 601–700 of 999
Detterich, J. A., Liu, H., Suriany, S., Kato, R. M., Chalacheva, P., Tedla, B. A., Shah, P., Khoo, M. C. K., Wood, J. C., Coates, T. D., et al. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.07.004 · Cited by 20
Total Serum Magnesium Levels and Calcium-To-Magnesium Ratio in Sickle Cell Disease
Antwi‐Boasiako, C., Kusi-Mensah, Y. A., Hayfron-Benjamin, C. F., Aryee, R., Dankwah, G. B., Abla, K. L., & Darkwa, E. O. (2019) · Medicina · doi:10.3390/medicina55090547 · Cited by 28
The potential of Angeli's salt to decrease nitric oxide scavenging by plasma hemoglobin
He, X., Azarov, I., Jeffers, A. B., Presley, T. D., Richardson, J., King, S. B., Gladwin, M. T., & Kim‐Shapiro, D. B. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.12.038 · Cited by 21
Self-citationEl-Shanshory, M. R., Badraia, I. M., Donia, A., El‐hameed, F. A., & Mabrouk, M. (2013) · European Journal Of Haematology · doi:10.1111/ejh.12114 · Cited by 22
Sickle cell disease in North Europe
Howard, J., & Davies, S. C. (2007) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365510601046441 · Cited by 25
Complicações cardiopulmonares das doenças falciformes
Gualandro, S. F. M., Fonsêca, G. H. H., & Gualandro, D. M. (2007) · Revista Brasileira de Hematologia e Hemoterapia · doi:10.1590/s1516-84842007000300020 · Cited by 29
Effects of a Single Sickling Event on the Mechanical Fragility of Sickle Cell Trait Erythrocytes
Presley, T. D., Perlegas, A. S., Bain, L. E., Ballas, S. K., Nichols, J. S., Sabio, H., Gladwin, M. T., Kato, G. J., & Kim‐Shapiro, D. B. (2010) · Hemoglobin · doi:10.3109/03630260903546999 · Cited by 24
Self-citationGonsalves, C. S., Li, C., Malik, P., Tahara, S. M., & Kalra, V. K. (2015) · Bioscience Reports · doi:10.1042/bsr20150190 · Cited by 22
Soluble CD163 levels in children with sickle cell disease
Møller, H. J., Nielsen, M. J., Bartram, J. L., Dick, M. C., Height, S. E., Moestrup, S. K., & Rees, D. C. (2011) · British Journal of Haematology · doi:10.1111/j.1365-2141.2011.08580.x · Cited by 20
Pathophysiological Associations and Measurement Techniques of Red Blood Cell Deformability
Liang, M.-H., Ming, D., Zhong, J.-W., Shannon, C. S., Rojas-Carabali, W., Agrawal, K., Ai, Y., & Agrawal, R. (2025) · Biosensors · doi:10.3390/bios15090566 · Cited by 21
Bünger, V., Hunsicker, O., Krannich, A., Balzer, F., Spies, C., Kuebler, W. M., Weber‐Carstens, S., Menk, M., & Graw, J. A. (2023) · Journal of Intensive Care · doi:10.1186/s40560-023-00664-5 · Cited by 23
Informational needs assessment of non‐Hodgkin lymphoma survivors and their physicians
Friedman, D. R., Sykes, A. D., Smith, S. K., Herndon, J. E., & Abernethy, A. P. (2010) · American Journal of Hematology · doi:10.1002/ajh.21725 · Cited by 22
Detterich, J. A., Sangkatumvong, S., Kato, R. M., Dongelyan, A., Bush, A., Khoo, M. C. K., Meiselman, H. J., Coates, T. D., & Wood, J. C. (2012) · Transfusion · doi:10.1111/j.1537-2995.2012.03961.x · Cited by 20
Stem-cell transplantation in children and adults with sickle cell disease: an update
Khoury, R. A., & Abboud, M. R. (2011) · Expert Review of Hematology · doi:10.1586/ehm.11.23 · Cited by 23
Estcourt, L. J., Fortin, P. M., Hopewell, S., Trivella, M., Hambleton, I. R., & Cho, G. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008360.pub4 · Cited by 18
Maloney, M. A., Ward, S. L. D., Su, J. A., Durazo-Arvizú, R., Breunig, J. M., Okpara, D. U., & Gillett, E. S. (2022) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.9944 · Cited by 25
A Prospective Appraisal of Pulmonary Hypertension in Children With Sickle Cell Disease
Sedrak, A., Rao, S. P., Miller, S. T., Hekmat, V., & Rao, M. (2009) · Journal of Pediatric Hematology/Oncology · doi:10.1097/mph.0b013e31818e5343 · Cited by 21
Update on Pulmonary Hypertension 2009
Gladwin, M. T., & Ghofrani, H. A. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201002-0235up · Cited by 22
Self-citationDifferential gene expression in pulmonary artery endothelial cells exposed to sickle cell plasma
Klings, E. S., Safaya, S., Adewoye, A. H., Odhiambo, A., Frampton, G. M., Lenburg, M. E., Gerry, N. P., Paola Sebastiani, B., Steinberg, M. H., & Farber, H. W. (2005) · Physiological Genomics · doi:10.1152/physiolgenomics.00246.2004 · Cited by 19
van Beers, E. J., Nur, E., Schaefer‐Prokop, C. M., Gillavry, M. R. M., van Esser, J. W. J., Brandjes, D. P. M., Kappers‐Klunne, M. C., Duits, A. J., Muskiet, F. A. J., Schnog, J. B., et al. (2008) · American Journal of Hematology · doi:10.1002/ajh.21272 · Cited by 21
Peng, C., Tsai, C., & Wu, K. (2008) · Hemoglobin · doi:10.1080/03630260701680078 · Cited by 19
Dessap, A. M., Dauger, S., Khellaf, M., Agbakou, M., Agut, S., Angoulvant, F., Arlet, J., Aubron, C., Baudin, F., Boissier, F., et al. (2025) · Annals of Intensive Care · doi:10.1186/s13613-025-01479-3 · Cited by 29
Buehler, P. W., Swindle, D. C., Pak, D. I., Fini, M. A., Hassell, K. L., Nuss, R., Wilkerson, R. B., D’Alessandro, A., & Irwin, D. C. (2021) · Pulmonary Circulation · doi:10.1177/20458940211055996 · Cited by 19
High risk and low prevalence diseases: Acute chest syndrome in sickle cell disease
Koehl, J. L., Koyfman, A., Hayes, B. D., & Long, B. (2022) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2022.06.018 · Cited by 29
Dovern, E., Aydin, M., DeBaun, M. R., Alizade, K., Biemond, B. J., & Nur, E. (2024) · American Journal of Hematology · doi:10.1002/ajh.27297 · Cited by 20
Musa, B. M., Galadanci, N. A., Coker, M. O., Bussell, S. A., & Aliyu, M. H. (2016) · Annals of Hematology · doi:10.1007/s00277-016-2693-z · Cited by 22
Pulmonary hypertension in Nigerian adults with sickle cell anemia
Amadi, V. N., Balogun, M. O., Akinola, N. O., Adebayo, R. A., & Akintomide, A. O. (2017) · Vascular Health and Risk Management · doi:10.2147/vhrm.s92799 · Cited by 20
Badawy, S. M., Payne, A. B., Rodeghier, M., & Liem, R. I. (2018) · European Journal Of Haematology · doi:10.1111/ejh.13140 · Cited by 18
d’Humières, T., Savale, L., Inamo, J., Deux, J., Deswarte, S., Lionnet, F., Loko, G., Chantalat, C., Damy, T., Guillet, H., et al. (2021) · American Journal of Hematology · doi:10.1002/ajh.26271 · Cited by 22
The pharmacotherapy of sickle cell disease
Wang, W. C. (2008) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560802519878 · Cited by 19
Complications pulmonaires des syndromes drépanocytaires majeurs chez l’adulte
Maître, B., Dessap, A. M., Habibi, A., Bachir, D., Parent, F., Godeau, B., & Galactéros, F. (2011) · Revue des Maladies Respiratoires · doi:10.1016/j.rmr.2010.08.013 · Cited by 18
The role of phosphodiesterase inhibitors in the management of pulmonary vascular diseases
BUTROUS, G. S. (2014) · Global Cardiology Science and Practice · doi:10.5339/gcsp.2014.42 · Cited by 22
Recommendations for the management of sickle cell disease in South Africa
Alli, N. A., Patel, M., Alli, H. D., Bassa, F., Coetzee, M., Davidson, A., Essop, M. R., Lakha, A., Louw, V. J., Novitzky, N., et al. (2014) · South African Medical Journal · doi:10.7196/samj.8470 · Cited by 22
Yousry, S. M., Ellithy, H. N., & Shahin, G. H. (2016) · Hematology · doi:10.1080/10245332.2016.1142710 · Cited by 18
Mondal, P., Stefek, B. P., Sinharoy, A., Sankoorikal, B.-J., Abu‐Hasan, M., & Aluquin, V. P. R. (2018) · Pediatric Research · doi:10.1038/s41390-018-0125-6 · Cited by 20
Wood, K. C., Durgin, B. G., Schmidt, H. M., Hahn, S. A., Baust, J., Bachman, T. N., Vitturi, D. A., Ghosh, S., Ofori-Acquah, S. F., Mora, A. L., et al. (2019) · Blood Advances · doi:10.1182/bloodadvances.2019000621 · Cited by 20
Self-citationGuía de práctica clínica para el diagnóstico y tratamiento de la hipertensión pulmonar
Galiè, N., Hoeper, M. M., Humbert, M. J. C., Torbicki, A., Vachiéry, J., Barberà, J. A., Beghetti, M., Corris, P. A., Gaine, S., Gibbs, J. S. R., et al. (2009) · Revista Española de Cardiología · doi:10.1016/s0300-8932(09)73130-6 · Cited by 25
Pulmonary hypertension of sickle cell disease: More than just another lung disease
Klings, E. S. (2007) · American Journal of Hematology · doi:10.1002/ajh.21083 · Cited by 19
Pulmonary hypertension in patients with sickle cell disease: not so frequent but so different
Simonneau, G., & Parent, F. (2011) · European Respiratory Journal · doi:10.1183/09031936.00119811 · Cited by 18
Under Pressure to Clarify Pulmonary Hypertension Clinical Risk
Maron, B. A., Wertheim, B. M., & Gladwin, M. T. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201711-2306ed · Cited by 17
Self-citationExtracellular Vesicles in Sickle Cell Disease: A Promising Tool
Lamarre, Y., Nader, É., Connes, P., Romana, M., & Garnier, Y. (2022) · Bioengineering · doi:10.3390/bioengineering9090439 · Cited by 17
Tantawy, A. A. G., Adly, A. A. M., & Ismail, E. A. R. (2012) · Blood Coagulation & Fibrinolysis · doi:10.1097/mbc.0b013e3283573a42 · Cited by 17
Abdul-Mohsen, M. F. (2012) · Journal of the Saudi Heart Association · doi:10.1016/j.jsha.2012.05.001 · Cited by 18
Cichowitz, C., Carroll, P. C., Strouse, J. J., Haywood, C., & Lanzkron, S. (2016) · Southern Medical Journal · doi:10.14423/smj.0000000000000511 · Cited by 17
Manifestations of sickle cell disease on thoracic imaging
Wang, M. X., Pepin, E. W., Verma, N., & Mohammed, T.-L. H. (2017) · Clinical Imaging · doi:10.1016/j.clinimag.2017.09.001 · Cited by 17
Bilan, V. P., Schneider, F., Novelli, E. M., Kelley, E. E., Shiva, S., Gladwin, M. T., Jackson, E. K., & Tofovic, S. P. (2018) · Pulmonary Circulation · doi:10.1177/2045894018791557 · Cited by 17
Self-citationJang, T., Mo, G., Stewart, C., Khoury, L., Ferguson, N., Egini, O., Muthu, J., Dutta, D., Salifu, M. O., & Lim, S. H. (2021) · Cell Transplantation · doi:10.1177/09636897211046559 · Cited by 18
Devanagondi, R., Zhang, X., Xu, Z., Ives, K. A., Levin, A. M., Gurm, H. S., & Owens, G. E. (2015) · Journal of Vascular and Interventional Radiology · doi:10.1016/j.jvir.2015.03.022 · Cited by 19
Raj, A. B., Condurache, T., Bertolone, S. J., Williams, D., Lorenz, D. J., & Sobczyk, W. L. (2005) · Pediatric Blood & Cancer · doi:10.1002/pbc.20521 · Cited by 17
Heart Rate Recovery Is Impaired after Maximal Exercise Testing in Children with Sickle Cell Anemia
Alvarado, A. M., Ward, K. M., Muntz, D. S., Thompson, A. A., Rodeghier, M., Fernhall, B., & Liem, R. I. (2014) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2014.10.064 · Cited by 18
Oguanobi, N. I., Ejim, E., Anisiuba, B. C., Onwubere, B., Ike, S. O., Ibegbulam, O. G., & Agwu, O. (2012) · ISRN Hematology · doi:10.5402/2012/768718 · Cited by 17
Rotz, S. J., O’Riordan, M. A., Kim, C., Lima, M. J. G. D., Gladwin, M. T., & Little, J. A. (2015) · Bone Marrow Transplantation · doi:10.1038/bmt.2015.11 · Cited by 18
Self-citationAdvances in new drug therapies for the management of sickle cell disease
Ataga, K. I., & Desai, P. C. (2018) · Expert Opinion on Orphan Drugs · doi:10.1080/21678707.2018.1471983 · Cited by 19
Bernaudin, F. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8101523 · Cited by 23
Caring for the Adult With Sickle Cell Disease: Results of a Multidisciplinary Pilot Program
Artz, N., Whelan, C. T., & Feehan, S. (2010) · Journal of the National Medical Association · doi:10.1016/s0027-9684(15)30727-6 · Cited by 19
Unraveling the hemolytic subphenotype of sickle cell disease
Gladwin, M. T. (2005) · Blood · doi:10.1182/blood-2005-08-3285 · Cited by 17
Self-citationSickle Cell Disease and Acute Chest Syndrome: Epidemiology, Diagnosis, Management, Outcomes
Sysol, J. R., & Machado, R. F. (2016) · Respiratory medicine · doi:10.1007/978-3-319-41912-1_4 · Cited by 25
Pulmonary hypertension in sickle cell disease
Kahf, S. A., Roche, A., Baron, A., Chantalat‐Auger, C., & Savale, L. (2023) · La Presse Médicale · doi:10.1016/j.lpm.2023.104209 · Cited by 16
Updated Role of Nitric Oxide in Disorders of Erythrocyte Function
Kahn, M. J., Maley, J. H., Lasker, G. F., & Kadowitz, P. J. (2013) · Cardiovascular & Haematological Disorders - Drug Targets · doi:10.2174/1871529x11313010009 · Cited by 17
Willen, S. M., & Gladwin, M. T. (2017) · Hematology · doi:10.1182/asheducation-2017.1.431 · Cited by 17
Self-citationImpact of cell-free hemoglobin on contracting skeletal muscle microvascular oxygen pressure dynamics
Ferguson, S. K., Harral, J. W., Pak, D. I., Redinius, K. M., Stenmark, K. R., Schaer, D. J., Buehler, P. W., & Irwin, D. C. (2018) · Nitric Oxide · doi:10.1016/j.niox.2018.03.005 · Cited by 15
Ventricular global longitudinal strain is altered in children with sickle cell disease
Whipple, N. S., Naik, R., Kang, G., Moen, J., Govindaswamy, S. D., Fowler, J. A., Dowdy, J., Penkert, R. R., Joshi, V. M., & Hankins, J. S. (2018) · British Journal of Haematology · doi:10.1111/bjh.15607 · Cited by 17
Yates, A. M., Joshi, V. M., Aygün, B., Moen, J., Smeltzer, M. P., Govindaswamy, D., Dowdy, J., Cotton, A., Kang, G., Ware, R. E., et al. (2019) · Pediatric Blood & Cancer · doi:10.1002/pbc.27717 · Cited by 17
Shah, P., Suriany, S., Kato, R. M., Bush, A., Chalacheva, P., Veluswamy, S., Denton, C. C., Russell, K., Khaleel, M., Forman, H. J., et al. (2020) · American Journal of Hematology · doi:10.1002/ajh.26003 · Cited by 16
Rai, P., Joshi, V. M., Goldberg, J. F., Yates, A. M., Okhomina, V. I., Penkert, R. R., Ataga, K. I., Kang, G., & Hankins, J. S. (2021) · Blood Advances · doi:10.1182/bloodadvances.2020003197 · Cited by 17
Piel, F. B., Jobanputra, M., Gallagher, M. E., Weber, J., Laird, S. G., & McGahan, M. (2021) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2021.102567 · Cited by 17
How do I transfuse patients with sickle cell disease?
Quirolo, K. C. (2010) · Transfusion · doi:10.1111/j.1537-2995.2010.02774.x · Cited by 16
Quimby, K. R., Hambleton, I. R., & Landis, R. C. (2015) · Medical Hypotheses · doi:10.1016/j.mehy.2015.06.023 · Cited by 17
Deambrogi, C., Paoli, L. D., Fangazio, M., Cresta, S., Rasi, S., Spina, V., Gattei, V., Gaïdano, G., & Rossi, D. (2010) · American Journal of Hematology · doi:10.1002/ajh.21742 · Cited by 19
Pulmonary hypertension in sickle cell disease: diagnosis and management
Ataga, K. I., & Klings, E. S. (2014) · Hematology · doi:10.1182/asheducation-2014.1.425 · Cited by 17
Marinho, C. D. L., Maioli, M. C. P., Soares, A. R., Bedirian, R., de Melo, P. L., Guimarães, F. S., Ferreira, A. D. S., & Lopes, A. J. (2016) · Journal of Bodywork and Movement Therapies · doi:10.1016/j.jbmt.2016.02.005 · Cited by 16
Kang, B., Park, K., Kleinhenz, J., Murphy, T. C., Sutliff, R. L., Archer, D. R., & Hart, C. M. (2016) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2016-0166oc · Cited by 19
Loomis, Z. L., Eigenberger, P., Redinius, K. M., Lisk, C., Karoor, V., Nozik‐Grayck, E., Ferguson, S. K., Hassell, K. L., Nuss, R., Stenmark, K. R., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0171219 · Cited by 17
Inamo, J., Connes, P., Barthélemy, J., Dan, V., Coates, T. D., & Loko, G. (2009) · American Journal of Hematology · doi:10.1002/ajh.21377 · Cited by 16
El-Beshlawy, A. M., Raouf, E. A. E., Mostafa, F., Talaat, M., Isma’eel, H., Aoun, E. G., Hoffbrand, A. V., & Taher, A. T. (2006) · Acta Haematologica · doi:10.1159/000089472 · Cited by 16
Orhan, K., Delilbaşı, Ç., & PAKSOY, C. S. (2009) · Dentomaxillofacial Radiology · doi:10.1259/dmfr/61024383 · Cited by 16
Venous thromboembolism and hormonal contraception
Pundir, J., & Coomarasamy, A. (2016) · Cambridge University Press eBooks · doi:10.1017/cbo9781316156513.068 · Cited by 16
Pulmonary hypertension in sickle cell disease.
Castro, O. L., Minniti, C. P., & Nouraie, M. S. (2011) · PubMed · doi:10.1056/nejmc1109130 · Cited by 12
Storti, F. (2008) · Cited by 16
Saramba, M. I., Shakya, S., & Zhao, D. (2020) · Jornal de Pediatria (Versão em Português) · doi:10.1016/j.jpedp.2019.05.024 · Cited by 23
Ramsey, S. D., Bender, M. A., Li, L., JOHNSON, K., Jiao, B., Devine, B., & Basu, A. (2022) · PLoS ONE · doi:10.1371/journal.pone.0278137 · Cited by 20
An exaggerated capillary endothelial edema may be the cause of sudden deaths in sickle cell diseases
Helvacı, M. R., Tuncsezen, U. K., Seckin, K., Piral, K., Seyhan, S., Karabacak, A. D., Camlibel, M., Abyad, A., & Pocock, L. (2023) · World Family Medicine Journal/Middle East Journal of Family Medicine · doi:10.5742/mewfm.2023.95256120 · Cited by 18
Low-dose warfarin may be a life-saving treatment regimen in sickle cell diseases
Helvacı, M. R., Varol, A., Onay, K., Abyad, A., & Pocock, L. (2023) · World Family Medicine Journal/Middle East Journal of Family Medicine · doi:10.5742/mewfm.2023.95256131 · Cited by 16
Pulmonary hypertension associated with autoimmune hemolytic anemia: A case report
Zhang, Y., Qui, Y., Zhu, J., & Gao, D. (2006) · International Journal of Cardiology · doi:10.1016/j.ijcard.2006.05.053 · Cited by 15
Greenough, A., Peacock, J. L., Zivanovic, S., Alcazar‐Paris, M., Lo, J., Marlow, N., & Calvert, S. (2014) · Health Technology Assessment · doi:10.3310/hta18410 · Cited by 15
Desai, P. C., Deal, A. M., Brittain, J. E., Jones, S., Hinderliter, A. L., & Ataga, K. I. (2012) · American Journal of Hematology · doi:10.1002/ajh.23278 · Cited by 18
Gaartman, A. E., Sayedi, A. K., Gerritsma, J. J., de Back, T. R., Tuijn, C. F. J. V., Tang, M. W., Heijboer, H., de Heer, K., Biemond, B. J., & Nur, E. (2021) · British Journal of Haematology · doi:10.1111/bjh.17696 · Cited by 21
Sharma, S., Efird, J. T., Kadali, R. A. K., Mehra, S., Chohan, H., Daggubati, R. B., Liles, D., Gouge, C. A., Boettger, P., & Knupp, C. (2013) · Clinical Cardiology · doi:10.1002/clc.22153 · Cited by 15
Desai, P. C., May, R., Jones, S., Strayhorn, D., Caughey, M. C., Hinderliter, A. L., & Ataga, K. I. (2013) · British Journal of Haematology · doi:10.1111/bjh.12453 · Cited by 15
Ráčil, Z., Rázga, F., Burešová, L., Jurček, T., Dvořáková, D., Žáčková, D., Timilsina, S., Cetkovský, P., & Mayer, J. (2010) · American Journal of Hematology · doi:10.1002/ajh.21722 · Cited by 18
NT‐proBNP as a marker of cardiopulmonary status in sickle cell anaemia in Africa
Aliyu, Z. Y., Suleiman, A., Attah, E. B., Mamman, A. I., Babadoko, A., Nouraie, M. S., Mendelsohn, L. G., Kato, G. J., Gordeuk, V. R., & Gladwin, M. T. (2010) · British Journal of Haematology · doi:10.1111/j.1365-2141.2010.08195.x · Cited by 19
Self-citationPulmonary hypertension in sickle cell disease
da Fonseca, G. W. P., & Souza, R. (2015) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000200 · Cited by 15
Free heme regulates placenta growth factor through NRF2-antioxidant response signaling
Kapetanaki, M. G., Gbotosho, O. T., Sharma, D., Weidert, F. L., Ofori-Acquah, S. F., & Kato, G. J. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.08.009 · Cited by 15
Pulmonary arterial hypertension in children: A Medical Update
Rosenzweig, E. B., & Barst, R. J. (2009) · The Indian Journal of Pediatrics · doi:10.1007/s12098-009-0032-2 · Cited by 15
Morris, C. R., Vichinsky, E. P., & Singer, S. T. (2007) · Advances in Pulmonary Hypertension · doi:10.21693/1933-088x-6.1.31 · Cited by 16
Survey sheds new light on marriage and sexuality in the Philippines.
Xenos, P. S. (1997) · PubMed · Cited by 15
Saudi guidelines on diagnosis and treatment of pulmonary arterial hypertension
Majdy, I., Al-Hajjaj, M. S., Javeed, K., Manal, A.-H., Alanezi, M. O., Saleemi, S., Sanai, F. M., Kashour, T. S., Wali, S., & Barst, R. J. (2008) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 14
Yin, X.-L., Zhang, X., Wu, Z., Zhao, D.-H., Zhou, Y., Yu, Y.-H., Liu, T.-N., Fang, S.-P., Tian-hong, Z., Wang, L., et al. (2013) · Acta Haematologica · doi:10.1159/000347177 · Cited by 14
Classification of Pulmonary Hypertension
McGlothlin, D. P. (2012) · Heart Failure Clinics · doi:10.1016/j.hfc.2012.04.013 · Cited by 14
Bello, N. A., Hyacinth, H. I., Roetker, N. S., Seals, S. R., Naik, R. P. P., Derebail, V. K., Kshirsagar, A. V., Key, N. S., Wilson, J. G., Correa, A., et al. (2016) · Blood · doi:10.1182/blood-2016-08-705541 · Cited by 14
Metadata
- Authors
- Gladwin, M. T., Sachdev, V., Jison, M. L., Shizukuda, Y., Plehn, J. F., Minter, K., Brown, B., Coles, W. A., Nichols, J. S., Ernst, I., Hunter, L. A., Blackwelder, W. C., Schechter, A. N., Rodgers, G. P., Castro, O., & Ognibene, F. P.
- Affiliations
- National Institutes of Health (US)
- National Heart, Lung, and Blood Institute (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2004-02-26
- Volume
- 350
- Issue
- 9
- Pages
- 886-895
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2148547093
- Cited by
- 1,325
- References
- 42
- Citations by year
- 2026: 42 · 2025: 30 · 2024: 45 · 2023: 44 · 2022: 42 · 2021: 47 · 2020: 34 · 2019: 61 · 2018: 43 · 2017: 57 · 2016: 74 · 2015: 64 · 2014: 76 · 2013: 64 · 2012: 68
- FWCI
- 35.46
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Digital Howard (Howard University) (submittedVersion)
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
- Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
- Keywords
- pulmonary hypertension, sickle cell disease, mortality risk, tricuspid regurgitation velocity, Doppler echocardiography, chronic hemolysis, hydroxyurea therapy, risk factors, alkaline phosphatase, lactate dehydrogenase, transferrin, cardiovascular complications, renal complications
- MeSH terms
- Adult, Anemia, Sickle Cell, Antisickling Agents, Blood Pressure, Cause of Death, Drug Resistance, Female, Hemolysis, Humans, Hydroxyurea, Hypertension, Pulmonary, Male, Pulmonary Artery, Risk Factors, Tricuspid Valve Insufficiency, Echocardiography, Doppler, Prevalence, Survival Rate, Logistic Models, Ventricular Function
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.